Average Co-Inventor Count = 7.77
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (21 from 3,681 patents)
2. Other (1 from 832,680 patents)
22 patents:
1. 12247058 - Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof
2. 12194110 - PD-L1 binding polypeptides for imaging
3. 12097241 - Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides
4. 12097242 - Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides
5. 11623013 - Methods and compositions for deuterated biologics
6. 11623965 - Prodruggable antibodies, prodrugs thereof, and methods of use and making
7. 11364281 - Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof
8. 11344639 - PET imaging with PD-L1 binding polypeptides
9. 11248031 - Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides
10. 11185570 - Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides
11. 11173219 - PD-L1 binding polypeptides for imaging
12. 10934572 - Serum albumin binding molecules
13. 10406251 - PD-L1 binding polypeptides for imaging
14. 10377806 - Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof
15. 10266578 - Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof